Surgery Partners posts Q3 net loss of $21.1 million; Q3 revenue falls to $815.3 million

By Public Technologies21:35 (UTC), 9 November 2026 Updated

Surgery Partners reported a third-quarter 2026 net loss attributable to the company of $21.1 million.
Revenue fell year over year to $815.3 million.
Operating cash flow climbed 24% year over year to $103.5 million.
The amended HealthSpan Partners merger agreement raises cash consideration to $25 per share, valuing the enterprise at up to approximately $6 billion.
The merger remains expected to close in the first quarter of 2027, subject to stockholder and regulatory approvals and customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Surgery Partners Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001638833-26-000089), on November 09, 2026, and is solely responsible for the information contained therein.